Puig, B.
University Medical Center Hamburg-Eppendorf
8 papers on CoChatORCID 0000-0002-2255-8393
Most cited papers
- Verified
Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration
Ferrer, I., Blanco, R., Carmona, M., Ribera, R., Goutan, E., Puig, B., Rey, M. J., Cardozo, A., Viñals, F., & Ribalta, T. (2001) · Brain Pathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 239
- Verified
Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice
Ribé, E. M., Pérez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., Sesma, T., Catena, S., Sánchez, B., Nieto, M., et al. (2005) · Neurobiology of Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 162
- Verified
Deposition of Hyperphosphorylated Tau in Cerebellum of PS1 E280A Alzheimer's Disease
Sepulveda‐Falla, D., Matschke, J., Bernreuther, C., Hagel, C., Puig, B., Villegas, A., Garcia, G., Zea, J., Gomez‐Mancilla, B., Ferrer, I., et al. (2011) · Brain Pathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 82
- Verified
Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies
Santpere, G., Nieto, M., Puig, B., & Ferrer, I. (2006) · Neuroscience Letters
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 70
- Verified
Phosphorylated Protein Kinases Associated with Neuronal and Glial Tau Deposits in Argyrophilic Grain Disease
Ferrer, I., Barrachina, M., Tolnay, M., Rey, M. J., Vidal, N., Carmona, M., Blanco, R., & Puig, B. (2003) · Brain Pathology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 60
- Verified
A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease
Sepulveda-Falla, D., Chavez-Gutierrez, L., Portelius, E., Vélez, J. I., Dujardin, S., Barrera-Ocampo, A., Dinkel, F., Hagel, C., Puig, B., Mastronardi, C., et al. (2021) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 54
- Verified
Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation
Ferrer, I., Pastor, P., Rey, M. J., Muñoz, E., Puig, B., Pastor, E., Oliva, R., & Tolosa, E. (2003) · Neuropathology and Applied Neurobiology
Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments
Cited by 48
- Verified
Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick?s disease
Puig, B., Vinals, F., & Ferrer, I. (2004) · Acta Neuropathologica
Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free